
Zejula Capsules 100 mg (Niraparib Tosylate Monohydrate)
159.4mg
Hard capsule · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.
Niraparib tosylate hydrate is an ingredient that exhibits anti-cancer effects by inhibiting the DNA repair of cancer cells.
MFDS ingredient code M269158
Niraparib tosylate hydrate belongs to the class of PARP inhibitors and induces cell death by disrupting the DNA repair process in cancer cells. It is mainly used for the treatment of certain types of cancer, including ovarian cancer.
This ingredient blocks the function of the PARP enzyme that repairs DNA damage within cancer cells. As a result, cancer cells are unable to repair their damaged DNA and ultimately die.
Approved uses differ by product. Check each product's information for its actual use.
Niraparib tosylate hydrate may have different indications and pharmacokinetics for specific types of cancer compared to other PARP inhibitors. It can be used as a monotherapy or in combination therapy, and the therapeutic effects and side effect profiles are distinct.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
4 total

159.4mg
Hard capsule · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.
79.7mg
Tablet · Prescription medication · Combination
Korea Janssen Co., Ltd.
159.4mg
Tablet · Prescription medication · Combination
Korea Janssen Co., Ltd.

159.3mg
Tablet · Prescription medication
Takeda Pharmaceutical Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.